AtaiBeckleyAtaiBeckley
AtaiBeckley

AtaiBeckley

A clinical-stage biopharmaceutical company developing psychedelic-based therapies for mental health disorders.

Website
2018Active95
Advertise here

About

AtaiBeckley is a global leader in the development of transformative mental health therapies, formed through the strategic combination of atai Life Sciences and Beckley Psytech in November 2025. The company is dedicated to developing innovative psychedelic-based neuroplastogens and related therapeutics to treat mental health disorders, including treatment-resistant depression and social anxiety disorder.

Technology stack

detected 2026-06-17
Est. monthly stack spend~$920/mo
CDN
Vercel
EmailMimecast
gateway-fronted
Hosting
Vercel
Stack
Next.jsTailwind CSS
Video
Vimeo
Email marketing
Mailchimp
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does AtaiBeckley do?

AtaiBeckley is a global leader in the development of transformative mental health therapies, formed through the strategic combination of atai Life Sciences and Beckley Psytech in November 2025. The company is dedicated to developing innovative psychedelic-based neuroplastogens and related therapeutics to treat mental health disorders, including treatment-resistant depression and social anxiety disorder.

How much funding has AtaiBeckley raised?

AtaiBeckley has raised a total of $640M in funding. The most recent round on record is Merger.

Where is AtaiBeckley headquartered?

AtaiBeckley is headquartered in New York, United States.

When was AtaiBeckley founded?

AtaiBeckley was founded in 2018.

What industry does AtaiBeckley operate in?

AtaiBeckley operates in Biotech & Life Sciences, MedTech, HealthTech, Drug Discovery, Clinical Trials, Mental Health Tech.

How many employees does AtaiBeckley have?

AtaiBeckley has approximately 95 people on record.